Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05143931 · ClinicalTrials.gov registry record · NA

Avoid and Resist Strategies for Weight Management

A NA study of Obesity and Overweight, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
NA
Development phase
503
Enrollment target
1
Study location

NCT05143931 is a NA study of Obesity and Overweight that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 503 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05143931, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
NA
Development phase
503 participants
Enrollment target
1
Study location

Study Summary

The proposed randomized controlled trial tests two self-regulatory approaches to improve intentional weight loss and diet quality in individuals with overweight or obesity: (1) an environmental control strategy (AVOID) and (2) an impulse control training strategy (RESIST).

Conditions Studied

Interventions

  • BEHAVIORAL Home food environment and grocery delivery (AVOID)
  • BEHAVIORAL Inhibitory control training (RESIST)
  • BEHAVIORAL WW

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 503 participants
Start Date 2022-06-06
Est. Completion 2027-02-09
Phase NA

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT05143931

The ClinicalTrials.gov registry entry for NCT05143931 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 503 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Home food environment and grocery delivery (AVOID) is the first listed.

NCT05143931 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05143931 about?

NCT05143931 is a clinical study titled "Avoid and Resist Strategies for Weight Management". The proposed randomized controlled trial tests two self-regulatory approaches to improve intentional weight loss and diet quality in individuals with overweight or obesity: (1) an environmental control strategy (AVOID) and (2) an impulse control training strategy (RESIST).

What is the current status of trial NCT05143931?

This trial is currently recruiting. It is a NA study. The enrollment target is 503 participants. The study started on 2022-06-06. Estimated completion is 2027-02-09.

What conditions does trial NCT05143931 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT05143931?

The interventions under investigation include: Home food environment and grocery delivery (AVOID) (BEHAVIORAL), Inhibitory control training (RESIST) (BEHAVIORAL), WW (BEHAVIORAL).

Who is sponsoring clinical trial NCT05143931?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05143931 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.